PRESS RELEASE published on 07/03/2025 at 21:19, 11 months 14 days ago Inside Information / Operations of the issuer (acquisitions, sales...) GenSight Biologics closes EUR 3.9M private placement with issuance of ordinary shares, pre-funded warrants, investor warrants. Funds to repay convertible bonds. Maxim Group, LLC acted as placement agent Private Placement Ordinary Shares GenSight Biologics Maxim Group EUR 3.9M
BRIEF published on 07/01/2025 at 08:59, 11 months 17 days ago GenSight Biologics raises nearly €4 million in private placement Private Placement Investment GenSight Biologics Euronext Shares LUMEVOQ ®
PRESS RELEASE published on 07/01/2025 at 08:54, 11 months 17 days ago Inside Information / Operations of the issuer (acquisitions, sales...) GenSight Biologics successfully completes private placement of nearly EUR 4 million, attracting new international investors. Funds to advance gene therapies for retinal diseases and CNS disorders Private Placement GenSight Biologics Gene Therapies Retinal Diseases CNS Disorders
BRIEF published on 06/26/2025 at 07:35, 11 months 22 days ago GenSight Biologics: Advances in Manufacturing Partnership with Catalent Gene Therapy GenSight Biologics LUMEVOQ® NOHL Catalent
PRESS RELEASE published on 06/26/2025 at 07:30, 11 months 22 days ago Inside Information / Other news releases GenSight Biologics achieves significant milestone with new manufacturing partnership with Catalent, successfully transferring upstream phase of LUMEVOQ® manufacturing process Gene Therapy GenSight Biologics LUMEVOQ Catalent Manufacturing Partnership
BRIEF published on 05/13/2025 at 22:05, 1 year 1 month ago GenSight Biologics Shareholders Approve Majority of Board's Resolutions Shareholder Meeting Board Resolutions GenSight Biologics LUMEVOQ® Phase III RECOVER
PRESS RELEASE published on 05/13/2025 at 22:00, 1 year 1 month ago Inside Information / Other news releases GenSight Biologics announces approval of all resolutions at Combined General Meeting on May 13, 2025. Company highlights achievements of 2024 and strategic priorities for 2025 Strategic Priorities Approval Combined General Meeting GenSight Biologics Achievements
BRIEF published on 04/23/2025 at 20:35, 1 year 1 month ago GenSight Biologics Announces Annual General Meeting Details Annual General Meeting Shareholders Gene Therapy GenSight Biologics Retinal Diseases
PRESS RELEASE published on 04/23/2025 at 20:30, 1 year 1 month ago Inside Information / Other news releases GenSight Biologics to hold Annual General Meeting on May 13, 2025 at 2:00 pm CEST in Paris, France. Procedures for obtaining preparatory documents outlined Annual General Meeting Preparatory Documents GenSight Biologics Gene Therapies Retinal Diseases
BRIEF published on 04/08/2025 at 07:51, 1 year 2 months ago GenSight Biologics Files its 2024 Universal Registration Document AMF Gene Therapy Registration Document GenSight Biologics Retina
Published on 06/18/2026 at 11:30, 28 minutes ago Deadline Extended for 2026 Semmelweis-Richter Journalism Award Applications
Published on 06/18/2026 at 00:00, 11 hours 58 minutes ago LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Published on 06/17/2026 at 23:30, 12 hours 28 minutes ago Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders
Published on 06/17/2026 at 22:50, 13 hours 8 minutes ago International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 13 hours 28 minutes ago Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/18/2026 at 11:30, 28 minutes ago 2026 Climate Transition Barometer: more than one in two European SMEs and mid-caps gain a tangible competitive advantage from decarbonisation (x3 vs. 2023)
Published on 06/18/2026 at 11:00, 58 minutes ago Mallia Aesthetics Reports Positive Results from Consumer Study with its Hormone-Free 8T3 Essentials Hair Serum
Published on 06/18/2026 at 11:00, 58 minutes ago Traum-Ferienwohnungen Launches Vision 360 to Bring AI-Powered Video Tours to Holiday Homeowners Across Europe
Published on 06/18/2026 at 11:00, 58 minutes ago ABB Ltd: ABB share buybacks - June 11, 2026 – June 17, 2026
Published on 06/18/2026 at 09:06, 2 hours 52 minutes ago Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany
Published on 06/18/2026 at 08:30, 3 hours 28 minutes ago OPmobility wins first awards with Chinese automaker Leapmotor outside of China
Published on 06/18/2026 at 07:00, 4 hours 58 minutes ago bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry
Published on 06/17/2026 at 17:40, 18 hours 18 minutes ago Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 1 day 3 hours ago Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
